Breaking News

You are here » Indian-Commodity  :  Equity & Shares  :  Biocon trades with traction on the bourses

24-Nov2017

Biocon trades with traction on the bourses

Biocon is currently trading at Rs. 416.55, up by 3.50 points or 0.85% from its previous closing of Rs. 413.05 on the BSE.

The scrip opened at Rs. 416.00 and has touched a high and low of Rs. 419.35 and Rs. 414.00 respectively. So far 116235 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 427.95 on 21-Nov-2017 and a 52 week low of Rs. 283.03 on 24-Nov-2016.

Last one week high and low of the scrip stood at Rs. 427.95 and Rs. 385.05 respectively. The current market cap of the company is Rs. 24918.00 crore.

The promoters holding in the company stood at 60.67%, while institutions and non-institutions held 19.23% and 20.10% respectively.

Biocon has launched KRABEVA, a biosimilar Bevacizumab for the treatment of patients with metastatic colorectal cancer and other types of lung, kidney, cervical, ovarian and brain cancers, in India.

KRABEVA, a monoclonal antibody (mAb) developed by Biocon, will help expand access to a world class, high quality biosimilar Bevacizumab for cancer patients in India. It is the world's first and only Bevacizumab with a unique 'Qual-Check' mechanism, which will ensure that patients get a quality-ascertained product right upto infusion.

Bevacizumab is indicated as a first-line treatment of patients with metastatic colorectal cancer (mCRC), and is accepted as a standard treatment option in combination with chemotherapy for patients with non-small-cell lung cancer (NSLC), metastatic renal cell carcinoma and recurrent ovarian cancer.

Biocon is India's largest and Asia's leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.


Related News

View all news

Tata Power trades higher on the bourses

Tata Power Company is currently trading at Rs. 71.40, up by 2.55 points or 3.70% from its previous closing of Rs. 68.85 on the BSE.The scrip opened at Rs. 70.00 and has touched a high and low of Rs. 71.45......

Glenmark shines with arm receiving USFDA's final approval for Hydrocortisone Valerate Cream

Glenmark Pharmaceuticals is currently trading at Rs. 610.00, up by 9.15 points or 1.52% from its previous closing of Rs. 600.85 on the BSE.The scrip opened at Rs. 606.90 and has touched a high and low......

Aditya Birla Capital rises on incorporating new wholly owned subsidiary

Aditya Birla Capital is currently trading at Rs. 108.00, up by 0.15 points or 0.14% from its previous closing of Rs. 107.85 on the BSE.The scrip opened at Rs. 109.00 and has touched a high and low of Rs.......

Top News

View all news

Ashiana Housing wins two awards

Ashiana Housing has won two awards. Realty Plus Awards 2018 has felicitated 'Ashiana Umang' as 'Best Themed Project' and the company's website as the 'Best Real Estate Website of the year'.Ashiana Umang......

Tata Power inaugurates second 'All-women' CRC in Mumbai

Tata Power has inaugurated its second 'All Women' Customer Relations Centre (CRC) in Borivali (East), Mumbai, with an aim to continue providing their talented and highly skilled women employees with new......

McLeod Russel hands over specified assets of eight Tea Estates to M K Shah Exports

McLeod Russel India has handed over the specified assets of the eight Tea Estates of the company to M K Shah Exports.Post completion of due diligence by M K Shah Exports (Buyer) and on compliance of the......